KRAS G12C inhibitors and methods of using the same
申请人:Amgen Inc.
公开号:US11090304B2
公开(公告)日:2021-08-17
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
申请人:Amgen Inc.
公开号:US20190343838A1
公开(公告)日:2019-11-14
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.